{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:19:17Z","timestamp":1787800757760,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Early-stage glottic cancer can be treated with radiotherapy only. Modern radiotherapy solutions allow for individualized dose distributions, hypofractionation and sparing of organs at risk. The target volume used to be the entire voice box. This series describe the oncological outcome and toxicity of individualized vocal cord-only hypofractionated radiotherapy for early stage (cT1a-T2 N0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study with patients treated in a single center between 2014 and 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 93 patients were included. Local control rate was 100% for cT1a, 97% for cT1b and 77% for cT2. Risk factor for local recurrence was smoking during radiotherapy. Laryngectomy-free survival was 90% at 5\u00a0years. Grade III or higher late toxicity was 3.7%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vocal cord-only hypofractionated radiotherapy appears to be oncologically safe in early-stage glottic cancer. Modern, image-guided radiotherapy led to comparable results as historical series with very limited late toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00405-023-07904-2","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T06:03:13Z","timestamp":1678168993000},"page":"3345-3352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma"],"prefix":"10.1007","volume":"280","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2530-3038","authenticated-orcid":false,"given":"Mischa","family":"de Ridder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde J. G.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J.","family":"Smid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A. H.","family":"Doornaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"7904_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.radonc.2016.02.006","volume":"118","author":"NM Lyhne","year":"2016","unstructured":"Lyhne NM et al (2016) Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent\u2014a population based study from the DAHANCA group. Radiother Oncol 118:257\u2013266. https:\/\/doi.org\/10.1016\/j.radonc.2016.02.006","journal-title":"Radiother Oncol"},{"key":"7904_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.oraloncology.2019.05.006","volume":"94","author":"G Di Credico","year":"2019","unstructured":"Di Credico G et al (2019) Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: a bivariate spline model approach. Oral Oncol 94:47\u201357. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.05.006","journal-title":"Oral Oncol"},{"key":"7904_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/CEJ.0b013e3282b6fd40","volume":"17","author":"C La Vecchia","year":"2008","unstructured":"La Vecchia C, Zhang ZF, Altieri A (2008) Alcohol and laryngeal cancer: an update. Eur J Cancer Prev 17:116\u2013124. https:\/\/doi.org\/10.1097\/CEJ.0b013e3282b6fd40","journal-title":"Eur J Cancer Prev"},{"key":"7904_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1023\/a:1021944123914","volume":"13","author":"R Talamini","year":"2002","unstructured":"Talamini R et al (2002) Combined effect of tobacco and alcohol on laryngeal cancer risk: a case\u2013control study. Cancer Causes Control 13:957\u2013964. https:\/\/doi.org\/10.1023\/a:1021944123914","journal-title":"Cancer Causes Control"},{"key":"7904_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ijc.21855","volume":"119","author":"C Bosetti","year":"2006","unstructured":"Bosetti C et al (2006) Trends in laryngeal cancer mortality in Europe. Int J Cancer 119:673\u2013681. https:\/\/doi.org\/10.1002\/ijc.21855","journal-title":"Int J Cancer"},{"key":"7904_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ijc.28388","volume":"134","author":"BA van Dijk","year":"2014","unstructured":"van Dijk BA, Karim-Kos HE, Coebergh JW, Marres HA, de Vries E (2014) Progress against laryngeal cancer in The Netherlands between 1989 and 2010. Int J Cancer 134:674\u2013681. https:\/\/doi.org\/10.1002\/ijc.28388","journal-title":"Int J Cancer"},{"key":"7904_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijrobp.2022.01.010","volume":"113","author":"P Pakkanen","year":"2022","unstructured":"Pakkanen P et al (2022) Survival and larynx preservation in early glottic cancer: a randomized trial comparing laser surgery and radiation therapy. Int J Radiat Oncol Biol Phys 113:96\u2013100. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.01.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7904_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10103-018-2695-2","volume":"34","author":"Y Ding","year":"2019","unstructured":"Ding Y, Wang B (2019) Efficacy of laser surgery versus radiotherapy for treatment of glottic carcinoma: a systematic review and meta-analysis. Lasers Med Sci 34:847\u2013854. https:\/\/doi.org\/10.1007\/s10103-018-2695-2","journal-title":"Lasers Med Sci"},{"key":"7904_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/hed.20500","volume":"29","author":"KM Goor","year":"2007","unstructured":"Goor KM et al (2007) Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck 29:128\u2013136. https:\/\/doi.org\/10.1002\/hed.20500","journal-title":"Head Neck"},{"key":"7904_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/MOO.0000000000000438","volume":"26","author":"M Hendriksma","year":"2018","unstructured":"Hendriksma M, Heijnen BJ, Sjogren EV (2018) Oncologic and functional outcomes of patients treated with transoral CO2 laser microsurgery or radiotherapy for T2 glottic carcinoma: a systematic review of the literature. Curr Opin Otolaryngol Head Neck Surg 26:84\u201393. https:\/\/doi.org\/10.1097\/MOO.0000000000000438","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"7904_CR11","doi-asserted-by":"publisher","first-page":"51S","DOI":"10.1177\/0145561320928198","volume":"100","author":"F Campo","year":"2021","unstructured":"Campo F et al (2021) Laser microsurgery versus radiotherapy versus open partial laryngectomy for T2 laryngeal carcinoma: a systematic review of oncological outcomes. Ear Nose Throat J 100:51S-58S. https:\/\/doi.org\/10.1177\/0145561320928198","journal-title":"Ear Nose Throat J"},{"key":"7904_CR12","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215122001682","author":"M Hendriksma","year":"2022","unstructured":"Hendriksma M et al (2022) Long term functional outcomes in T2 glottic carcinoma after radiotherapy. J Laryngol Otol. https:\/\/doi.org\/10.1017\/S0022215122001682","journal-title":"J Laryngol Otol"},{"key":"7904_CR13","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1002\/hed.26841","volume":"43","author":"A Amini","year":"2021","unstructured":"Amini A et al (2021) Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer. Head Neck 43:3393\u20133403. https:\/\/doi.org\/10.1002\/hed.26841","journal-title":"Head Neck"},{"key":"7904_CR14","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.21873\/invivo.12101","volume":"34","author":"G Suzuki","year":"2020","unstructured":"Suzuki G et al (2020) Comparison of three fractionation schedules in radiotherapy for early glottic squamous cell carcinoma. In Vivo 34:2769\u20132774. https:\/\/doi.org\/10.21873\/invivo.12101","journal-title":"In Vivo"},{"key":"7904_CR15","doi-asserted-by":"publisher","first-page":"105782","DOI":"10.1016\/j.oraloncology.2022.105782","volume":"127","author":"L Tans","year":"2022","unstructured":"Tans L et al (2022) Single vocal cord irradiation for early-stage glottic cancer: excellent local control and favorable toxicity profile. Oral Oncol 127:105782. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.105782","journal-title":"Oral Oncol"},{"key":"7904_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3109\/0284186X.2015.1006401","volume":"54","author":"J Caldas-Magalhaes","year":"2015","unstructured":"Caldas-Magalhaes J et al (2015) The accuracy of target delineation in laryngeal and hypopharyngeal cancer. Acta Oncol 54:1181\u20131187. https:\/\/doi.org\/10.3109\/0284186X.2015.1006401","journal-title":"Acta Oncol"},{"key":"7904_CR17","doi-asserted-by":"publisher","first-page":"e2465","DOI":"10.7759\/cureus.2465","volume":"10","author":"H Ligtenberg","year":"2018","unstructured":"Ligtenberg H et al (2018) Target volume delineation using diffusion-weighted imaging for MR-guided radiotherapy: a case series of laryngeal cancer validated by pathology. Cureus 10:e2465. https:\/\/doi.org\/10.7759\/cureus.2465","journal-title":"Cureus"},{"key":"7904_CR18","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.ijrobp.2005.05.018","volume":"63","author":"E Cellai","year":"2005","unstructured":"Cellai E et al (2005) Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 63:1378\u20131386. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.05.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7904_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091319","author":"M Hendriksma","year":"2019","unstructured":"Hendriksma M et al (2019) Survival and prognostic factors for outcome after radiotherapy for T2 glottic carcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11091319","journal-title":"Cancers (Basel)."},{"key":"7904_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","volume":"78","author":"BS Chera","year":"2010","unstructured":"Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM (2010) T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 78:461\u2013466. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.08.066","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7904_CR21","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.ijrobp.2009.07.1687","volume":"77","author":"BS Chera","year":"2010","unstructured":"Chera BS, Amdur RJ, Morris CG, Mendenhall WM (2010) Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys 77:1380\u20131385. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1687","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7904_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3389\/fonc.2019.00932","volume":"9","author":"O Elicin","year":"2019","unstructured":"Elicin O et al (2019) Influencing factors on radiotherapy outcome in stage I\u2013II glottic larynx cancer\u2014a multicenter study. Front Oncol 9:932. https:\/\/doi.org\/10.3389\/fonc.2019.00932","journal-title":"Front Oncol"},{"key":"7904_CR23","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/hed.26308","volume":"42","author":"KA Al Feghali","year":"2020","unstructured":"Al Feghali KA et al (2020) Outcomes after radiation therapy for T2N0\/stage II glottic squamous cell carcinoma. Head Neck 42:2791\u20132800. https:\/\/doi.org\/10.1002\/hed.26308","journal-title":"Head Neck"},{"key":"7904_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4103\/0973-1482.163679","volume":"11","author":"D Chauhan","year":"2015","unstructured":"Chauhan D et al (2015) Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas. J Cancer Res Ther 11:746\u2013751. https:\/\/doi.org\/10.4103\/0973-1482.163679","journal-title":"J Cancer Res Ther"},{"key":"7904_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.01.050","author":"CE Cardenas","year":"2022","unstructured":"Cardenas CE et al (2022) Comprehensive quantitative evaluation of variability in MR-guided delineation of oropharyngeal gross tumor volumes and high-risk clinical target volumes: an R-IDEAL stage 0 prospective study. Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.01.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7904_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/s0360-3016(02)04572-8","volume":"56","author":"B van Asselen","year":"2003","unstructured":"van Asselen B, Raaijmakers CP, Lagendijk JJ, Terhaard CH (2003) Intrafraction motions of the larynx during radiotherapy. Int J Radiat Oncol Biol Phys 56:384\u2013390. https:\/\/doi.org\/10.1016\/s0360-3016(02)04572-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7904_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.semradonc.2003.10.006","volume":"14","author":"P Keall","year":"2004","unstructured":"Keall P (2004) 4-Dimensional computed tomography imaging and treatment planning. Semin Radiat Oncol 14:81\u201390. https:\/\/doi.org\/10.1053\/j.semradonc.2003.10.006","journal-title":"Semin Radiat Oncol"},{"key":"7904_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.radonc.2018.09.015","volume":"130","author":"T Bruijnen","year":"2019","unstructured":"Bruijnen T et al (2019) Intrafraction motion quantification and planning target volume margin determination of head-and-neck tumors using cine magnetic resonance imaging. Radiother Oncol 130:82\u201388. https:\/\/doi.org\/10.1016\/j.radonc.2018.09.015","journal-title":"Radiother Oncol"},{"key":"7904_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00405-013-2608-8","volume":"271","author":"A Al-Mamgani","year":"2014","unstructured":"Al-Mamgani A et al (2014) Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy. Eur Arch Otorhinolaryngol 271:125\u2013132. https:\/\/doi.org\/10.1007\/s00405-013-2608-8","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"7904_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijrobp.2019.02.047","volume":"110","author":"CW Song","year":"2021","unstructured":"Song CW et al (2021) Biological principles of stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS): indirect cell death. Int J Radiat Oncol Biol Phys 110:21\u201334. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.02.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7904_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijrobp.2019.03.010","volume":"105","author":"DJ Sher","year":"2019","unstructured":"Sher DJ et al (2019) Phase 1 fractional dose-escalation study of equipotent stereotactic radiation therapy regimens for early-stage glottic larynx cancer. Int J Radiat Oncol Biol Phys 105:110\u2013118. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.03.010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-07904-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-023-07904-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-07904-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T07:10:06Z","timestamp":1685085006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-023-07904-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["7904"],"URL":"https:\/\/doi.org\/10.1007\/s00405-023-07904-2","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Identification of meetings"}}]}}